Plasma assays of Alzheimer-s disease biomarkers (abeta42, abeta40, ptau217 ) using... Tender

Procurement Summary

Country : USA

Summary : Plasma assays of Alzheimer-s disease biomarkers (abeta42, abeta40, ptau217 ) using the Lumipulse assays on the Fujirebio G1200 in the Baltimore Longitudinal Study of Aging (BLSA)

Deadline : 11 Apr 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 116957218

Document Ref. No. : 75N95025Q00186

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

(i) This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.



(ii) The solicitation number is 75N95025Q00186 and the solicitation is issued as a request for quotation (RFQ).



This acquisition is for a commercial product or commercial service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Products and Commercial Services, and is not expected to exceed the simplified acquisition threshold.



THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL AND OPEN COMPETITION (INCLUDING BRAND-NAME).



The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institute on Aging, intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Johns Hopkins Bayview Medical Center, 5200 Eastern Avenue, Room 5100, MFL Center Tower, Baltimore, MD 21224 for plasma assays of Alzheimer-s disease biomarkers (abeta42, abeta40, ptau217 ) using the Lumipulse assays on the Fujirebio G1200 in the Baltimore Longitudinal Study of Aging (BLSA).



This acquisition is conducted as non-competitive for a commercial product or commercial service and is conducted pursuant to FAR 13.106-1(b)(1).



(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2025-03, with effective date 01/17/2025.



(iv) The associated NAICS code is 621511 and the small business size standard ...
Active Contract Opportunity
Notice ID : 75N95025Q00186
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
Original Published Date: Mar 28, 2025 07:36 am EDT
Original Date Offers Due: Apr 11, 2025 09:00 am EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Apr 26, 2025
Initiative: None

Classification
Original Set Aside:
Product Service Code: Q301 - REFERENCE LABORATORY TESTING
NAICS Code: 621511 - Medical Laboratories

Place of Performance: Baltimore, MD 21224 USA

Documents

 Tender Notice

D-FAR-52.pdf

D-FAR-52.pdf

D-Invoicing-Instructions-With-IPP-3-23.pdf

D-FAR-52.pdf

D-FAR-52.pdf

D-FAR-52.pdf

D-Statement-of-Work.pdf